NASDAQ:SMMT | Income Statement | Summit Therapeutics Inc.

Complete source-backed income-statement history.

Available history
2019-01-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$157.73M$220.5M$4.8M-$215.7M-$0.28-$0.28778,184,568778,184,568
2026-03-31$132.62M$195.21M$5.79M-$189.42M-$0.24-$0.24775,458,141775,458,141
2025-12-31$224.93M$5.75M-$219.17M-$0.28-$0.286,313,7296,313,729
2025-09-30$234.21M$2.42M-$231.79M-$0.31-$0.31743,415,917743,415,917
2025-06-30$208.02M$568.44M$2.73M-$565.71M-$0.76-$0.76742,615,007742,615,007
2025-03-31$51.27M$66.85M$3.94M-$62.91M-$0.09-$0.09738,076,003738,076,003
2024-12-31$0.00$65.61M-$65.61M$4.42M-$61.2M-$0.09-$0.096,373,5156,373,515
2024-09-30$0.00$58.38M-$58.38M$4.58M-$56.25M-$0.08-$0.08726,656,045726,656,045
2024-06-30$59.62M-$59.62M$2.33M-$60.39M-$0.09-$0.09707,904,643707,904,643
2024-03-31$30.87M$42.39M-$42.39M$2.04M-$43.47M-$0.06-$0.06701,785,250701,785,250
2023-12-31$0.00$24.81M$35.39M-$36.21M$16.1M-$36.57M-$0.01-$0.0127,279,30027,279,300
2023-09-30$0.00$15.32M$20.76M-$20.49M-$776,000.00-$21.27M-$0.03-$0.03697,739,477697,739,477
2023-06-30$0.00$9.45M$15.77M-$15.79M$1.08M-$14.72M-$0.02-$0.02697,685,365697,685,365
2023-03-31$0.00$9.88M$537.74M-$537.15M-$5.22M-$542.38M-$1.43-$1.43378,163,980378,163,980
2022-12-31$0.00$5.39M$21.43M-$20.3M$5.47M-$19.23M-$0.04-$0.0431,489,71831,489,718
2022-09-30$220,000.00$17.05M$22.62M-$16.94M-$4.45M-$21.39M-$0.10-$0.10208,909,351208,909,351
2022-06-30$235,000.00$9.01M$15.94M-$12.69M-$4.08M-$16.77M-$0.12-$0.12140,114,997140,114,997
2022-03-31$250,000.00$20.56M$27.22M-$22.16M$761,000.00-$21.4M-$0.15-$0.15140,040,370140,040,370
2021-12-31$251,000.00$23.11M$30.89M-$26.05M-$1.05M-$27.1M$0.00-$27.1M$0.00$0.0039,942,93939,942,939
2021-09-30$1.31M$19.94M$25.61M-$19.49M-$113,000.00-$19.6M$0.00-$19.6M-$0.20-$0.2098,973,91098,973,910
2021-06-30$57,000.00$23.92M$29.91M-$23.73M-$686,000.00-$24.42M$0.00-$24.42M-$0.27-$0.2792,065,95792,065,957
2021-03-31$192,000.00$18.38M$22.56M-$16.92M-$565,000.00-$17.49M$0.00-$17.49M-$0.21-$0.2182,817,83682,817,836
2020-12-31$185,000.00$13.06M$16.1M-$11.56M-$2.01M-$13.56M-$21,000.00-$13.54M-$0.18-$0.182,296,9642,296,964
2020-09-30$181,000.00$13.73M$21.43M-$16.94M-$858,000.00-$17.8M-$56,000.00-$17.74M-$0.26-$0.2667,231,90067,231,900
2020-06-30$170,000.00$13.57M$19.35M-$15.36M-$114,000.00-$15.47M-$191,000.00-$15.28M-$0.23-$0.2367,231,90067,231,900
2020-03-31$324,000.00$12.91M$16.48M-$9.34M$3.26M-$6.08M$55,000.00-$6.13M-$0.09-$0.0967,217,70167,217,701
2019-09-30$148,000.00$9.95M$12.63M-$6.19M-$6.27M$111,000.00-$6.38M-$0.20-$0.2032,099,00032,099,000

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$1.09B$14.84M-$1.08B$0.00-$1.08B-$1.44-$1.44747,702,265747,702,265
2024-12-31$0.00$226M-$226M$13.37M-$221.32M$0.00-$221.32M-$0.31-$0.31718,541,896718,541,896
2023-12-31$0.00$59.47M$609.65M-$609.65M$11.18M-$614.93M$0.00-$614.93M-$0.99-$0.99619,646,180619,646,180
2022-12-31$705,000.00$52M$87.21M-$72.09M-$2.29M-$78.78M-$78.78M-$0.41-$0.41193,336,063193,336,063
2021-12-31$1.81M$85.35M$108.96M-$86.19M-$2.42M-$88.6M$0.00-$88.6M-$0.67-$0.67131,714,225131,714,225
2020-12-31$860,000.00$53.27M$73.37M-$53.19M$283,000.00-$52.91M-$213,000.00-$52.7M-$0.76-$0.7669,524,14869,524,148
2019-12-31$743,000.00$39.81M$51.09M-$27.47M-$1.62M-$29.09M$36,000.00-$29.13M-$0.89-$0.8932,829,00332,829,003
2019-01-31$57.09M$52M$74.31M$5.39M$3.69M$9.08M-$1.79M$10.87M$0.63$0.6317,140,49417,228,718

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.